Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age
NCT00244621
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
95
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
candesartan cilexetil (Atacand)
DRUG:
candesartan cilexetil (Atacand)
DRUG:
candesartan cilexetil (Atacand)
Sponsor
AstraZeneca